Russia approves second COVID-19 vaccine after preliminary trials

scroll for the Story

~ MORE ~

'কিছু স্লিপার সেল সক্রিয় হলেও আইনশৃঙ্খলা বাহিনী সতর্ক আছে'। জঙ্গি হামলার জন্য কিছু স্লিপার সেল সক্রিয় হলেও আইনশৃঙ্খলা রক্ষাকারী বাহিনী
UK to carry out a MILLION covid tests a day by Christmas Both sides are under pressure to come to
Attention Required! | Cloudflare Attention Required! | Cloudflare Please enable cookies.Why do I have to complete a CAPTCHA?Completing the CAPTCHA
Breaking news on Palantir IPO CNBC's Steve Liesman previews Fed Chair Jerome Powell's speech on Thursday, and what he may
Kristen Stewart Cast as Princess Diana in Movie About Decision to End Marriage with Prince Charles The film will take
Buried lakes of liquid water discovered on Mars The underground lakes were detected in the Red Planet's south polar region.
Attorneys and family of Jacob Blake hold news conference Attorneys and family of Jacob Blake hold a news conference in
Stimulus will help everybody: Hennessy Funds David Ellison Earnings from the largest banks are expected to come this week. David
মাস্ক পরায় সচেতনতা মাস্ক পরে নাক–মুখ ঢেকে বেরোনো এখন দৈনন্দিন জীবনেরই অংশ। মাস্ক না পরে বাইরে বের হলে সংক্রামক ব্যাধি
Trump Amplifies His Message Of Racial Resentment | Morning Joe | MSNBC As the coronavirus continues to rage across the

explore a.

all Story at a.

✐ Publish
👁️‍🗨️ Perceive
🙂 Play
TrendingStory
SocialStory
RandomStory

Your concerned Story here:

Russia approves second COVID-19 vaccine after preliminary trials

By Reuters Staff

2 Min Read

MOSCOW (Reuters) – Russia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines.

Slideshow ( 3 images )

A delighted President Vladimir Putin announced the news at a government meeting on Wednesday.

The jab was developed by the Vector Institute in Siberia and completed early-stage human trials last month. However, results have not been published yet and a large-scale trial, known as Phase III, has not yet begun.

“We need to increase production of the first and second vaccine,” Putin said in comments broadcast on state TV.

“We are continuing to cooperate with our foreign partners and will promote our vaccine abroad.”

The peptide-based vaccine, named EpiVacCorona, is the second to be licensed for use in Russia. There has been a placebo-controlled trial on 100 volunteers between 18 and 60 in Novosibirsk.

A shot developed by Moscow’s Gamaleya Institute, Sputnik V, was licensed for domestic use in August.

That vaccine, based on an adenovirus vector, was also registered before Phase III trials. A trial involving 40,000 participants is now under way in Moscow.

A large-scale human trial of EpiVacCorona is likely to begin in November or December, the TASS news agency cited the consumer safety watchdog Rospotrebnadzor, which oversees the institute, as saying this month.

The trial is expected to involve 30,000 volunteers, of whom the first 5,000 will be residents of Siberia, according to the Interfax news agency.

Hundreds of people in professions that put them at high risk of coronavirus infection have now also received the Gamaleya jab, according to the health ministry, but the vaccine is not yet in general use.

Since the start of the pandemic, Russia has recorded more than 1,340,000 infections, fourth in the world behind the United States, India and Brazil.

Another vaccine against COVID-19 is being developed by the Chumakov Institute in St Petersburg. It plans to start an early-stage clinical trial involving around 300 people on Oct. 19.

Reporting by Vladimir Soldatkin and Polina Ivanova; writing by Gabrielle Tétrault-Farber and Polina Ivanova; Editing by Kevin Liffey


as per our monitoring this Story originally appeared

* : ) here → *


Russia approves second COVID-19 vaccine after preliminary trials

Have A Say ?

Pay A Visit :

SCUC-CCP :: Selective Cause Until it is Concluded : Coronavirus Covid-19 Pandemic

7

We've thought not to show typical, irritating Google adsense to give you an ad-free, calm internet experience always. But it depends on your continuous support for our this distinguished initiative, whenever we see our Donation Model reaches equivalent to Google Adsense earnings, we'll stop showing google ads. Make a donation of just $1 (we wont want more indeed).

Leave a Comment

Your email address will not be published.